Production Platform
Through our core technical capabilities in modern traditional Chinese medicine (TCM) and advanced controlled-release formulations, Baheal Medical has established a sophisticated R&D and production system for both TCM and chemical medicines. We have successfully launched a variety of innovative products with proprietary intellectual property rights, and consistently drive forward technological development and production for upstream medical innovations.
Shanghai - Modern TCM R&D and Production BaseQingdao - Advanced Controlled-release Formulation R&D and Production Base
As a modern TCM R&D and manufacturing platform, it aims to inherit and promote traditional Chinese medicine. With modernization, standardization, and globalization of TCM as its mission, it adheres to the concept of diagnosable diseases, controllable quality, and traceable efficacy, building a full industrial chain of modern TCM.
24600㎡
Land Area
2.59Billion tablets
Annual production capacity
As an advanced controlled-release formulation R&D and manufacturing platform, it focuses on the R&D and commercial production of advanced formulation technologies such as osmotic pumps and pellet coating matrix tablets. The base covers an area of 85,600 m² with a production capacity of 6.5 billion tablets per year.
· Co-production and sales in China and the USA, with multiple products simultaneously registered and sold in both markets.
cGMP Certification by FDA
"Zero Defect", Co-production and sales in China and the USA
85600㎡
Land Area
6.5Billion tablets
Annual production capacity
